Influence of β2-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol

Annals of Allergy, Asthma and Immunology

Volumn 110, Issue 3, 2013, Pages 156-160

  Giubergia, Verónica ^a   Gravina, Luis ^a   Castaños, Claudio ^a   Chertkoff, Lilien ^a  

^a Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; FLUTICASONE PROPIONATE; SALMETEROL;

ADOLESCENT; ARGENTINA; ARTICLE; ASTHMA; BETA2 ADRENERGIC RECEPTOR GENE; CHILD; CHILD HOSPITALIZATION; CODON; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; ARGENTINA; ASTHMA; CHILD; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENOTYPE; HOSPITALIZATION; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; RESPIRATORY FUNCTION TESTS;

EID: 84875213990     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.12.018     Document Type: Article

References (36)

1. G. Hawkins, K. Tantisira, and D. Meyers Sequence, haplotype and association analysis of ADRB2 in a multiethnic asthma case-control study Am J Respir Crit Care Med 174 2006 1101 1109
2. D.R. Taylor, J.M. Drazen, and G.P. Herbison Asthma exacerbations during long term B-agonist use: influence of B2 adrenoceptor polymorphism Thorax 55 2000 762 767
3. E. Israel, J.M. Drazen, and S.B. Liggett The effect of polymorphisms of the B2-adrenergic receptor on the response to regular use of albuterol in asthma Am J Respir Crit Care Med 162 2000 75 80
4. E. Israel, V.M. Chinchilli, and J.G. Ford National Heart, Lung, and Blood Institute's Asthma Clinical Research Network Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial Lancet 364 2004 1505 1512
5. A.E. Tattersfield, and T.W. Harrison B-Adrenoceptor polymorphisms: focus moves to long-acting β-agonists Am J Respir Crit Care Med 173 2006 473 474
6. M.E. Wechsler, E. Lehman, and S.C. Lazarus Beta-adrenergic receptor polymorphisms and response to salmeterol Am J Crit Care Med 173 2006 519 526
7. C.N. Palmer, B.J. Lipworth, and S. Lee Arginine-16 B2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol Thorax 61 2006 940 944
8. Global Initiative for Asthma, National Heart, Lung, and Blood Institute. Global strategy for asthma management and prevention. http://www.ginasthma.org. Accessed December 31, 2012.
9. G. Flores, M. Abreu, S. Tomany-Korman, and J. Meurer Keeping children with asthma out of hospitals: parents' and physicians' perspectives on how pediatric asthma hospitalizations can be prevented Pediatrics 116 2005 957 965
10. 2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children Pediatr Pulmonol 43 2008 421 425
11. 2-Adrenergic polymorphisms and total serum IgE levels in children with asthma from Argentina Ann Allergy Asthma Immunol 102 2009 308 313
12. H. Reddel, R. Taylor, and E.D. Bateman An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations Am J Respir Crit Care Med 180 2009 59 99
13. ATS Statement: snowbird workshops on standardization of spirometry Am Rev Dis 127 1983 725 735
14. F.D. Martinez, P.E. Graves, M. Baldini, S. Solomon, and R. Erickson Association between genetic polymorphism of the β2-agonist adrenoceptor and response to albuterol in children with and without a history of wheezing J Clin Invest 100 1997 3184 3188
15. S. Wenzel Physiologic and pathologic abnormalities in severe asthma Clin Chest Med 27 2006 29 40
16. J.M. Drazen, E.K. Silverman, and T.H. Lee Heterogeneity of therapeutic responses in asthma Br Med Bull 56 2000 1054 1070
17. H.S. Castle, R. Fuller, J. Hall, and J. Palmer Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require bronchodilator treatment BMJ 306 1993 1034 1037
18. H.S. Nelson, S.T. Weiss, E.R. Bleecker, S.W. Yancey, and P.M. Dorinsky The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol Chest 129 2006 15 26
19. H. Bisgaard Long-acting B2-agonists in management of childhood asthma: a critical review of the literature Pediatr Pulmonol 29 2000 221 234
20. B.A. Chowdry, and G. Dal Pan The FDA and safe use of long-acting beta agonists in the treatment of asthma N Engl Med 362 2010 1169 1171
21. 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitization in moderately severe stable asthmatics Lancet 350 1997 995 999
22. 2-agonist in asthma (LARGE trial): a genotype-stratified, randomized, placebo-controlled, crossover trial Lancet 374 2009 1754 1764
23. K. Basu, C.N. Palmer, R. Tavendale, B.J. Lipworth, and S. Mukhopadhyay Adrenergic B2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol J Allergy Clin Immunol 124 2009 1188 1194
24. E. Bleecker, D. Postma, and R.M. Lawrance Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy: a pharmacogenetic analysis of two randomized studies Lancet 370 2007 2118 2125
25. 2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate Am J Respir Crit Care Med 181 2010 676 687
26. Consensus on Bronchial Asthma 2007. 2nd. Part. Comité Nacional de Neumonología, Comité Nacional de Alergia, Comité Nacional de Familia y Salud Mental y Comité Nacional de Medicina Interna Arch Argent Pediatr 106 2008 162 175
27. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma, a National Clinical Guideline. http://www.brit-thoracic.org.uk/. Accessed December 31, 2011.
28. D.K. Lee, G.P. Currie, I.P. Hall, J.J. Lima, and B.J. Lipworth The arginine-16 B2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol Br J Clin Pharmacol 57 2003 68 75
29. C. Rebordosa, M. Kogevinas, and S. Guerra ADRB2 Gly16Arg polymorphism, asthma control and lung function decline Eur Respir J 38 2011 1029 1035
30. 2- adrenoreceptor agonists enhance the clinical efficacy of inhaled corticosteroids Br J Pharmacol 153 2008 1090 1104
31. P.R. Cooper, and R.A. Panettieri Steroids completely reverse albuterol induced B2-adrenergic receptor tolerance in human small airways J Allergy Clin Immunol 122 2008 734 740
32. J.C. Mak, T. Hisada, M. Salmon, P.J. Barnes, and K.F. Chung Glucocorticoids reverse IL-1β induced impairment of β-adrenoreceptor- mediated relaxation and up-regulation of G-protein-coupled receptor kinases Br J Pharmacol 135 2002 987 996
33. 2-adrenergic receptor transcription in human lung Am J Physiol 268 1995 L41 L46
34. K.S. Tan, A. Grove, and A. McLean Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients Am J Respir Crit Care Med 156 1997 28 35
35. S. Kalra, V.A. Swystun, R. Bhagat, and D.W. Cockcroft Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol Chest 109 1996 953 956
36. 2-agonists in asthma Drug Safety 27 2004 243 270